<DOC>
	<DOCNO>NCT02639156</DOCNO>
	<brief_summary>To evaluate tolerance acceptability AYMES LONDON patient require supplementary oral nutritional support compare currently available alternative .</brief_summary>
	<brief_title>Acceptability Tolerance New Oral Nutritional Supplement</brief_title>
	<detailed_description>TITLE EVALUATION OF TOLERANCE AND ACCEPTABILITY OF AYMES LONDON STUDY OBJECTIVES - To evaluate tolerance acceptability AYMES LONDON patient require supplementary oral nutritional support compare currently available alternative . - To obtain data support ACBS submission AYMES LONDON ( allow prescription community NHS expense ) . STUDY DESIGN Interventional study . STUDY POPULATION 20 patient establish oral nutritional supplement ( ONS ) , require nutritional supplementation least 300kcal/day . Patients reside community setting ( e.g . home , care home community hospital ) STUDY PRODUCTS AYMES LONDON Patients ' current oral nutritional supplement STUDY GROUPS This observational study patient act control , one study group contain patient STUDY OUTLINE Baseline : After recruitment patient remain current oral nutritional supplement 3 day , time baseline tolerance data record ( number consistency bowel movement , daily , volume ONS take , episodes nausea , vomit , burping , abdominal pain , bloat diarrhoea ) . A three-day food diary keep record total oral intake . Patients also anthropometric measurement carry period ( weight , height , body mass index ( BMI ) ) . Intervention Period : Patients change onto equivalent prescription AYMES LONDON period 9 day . Tolerance data record daily first 2 day AYMES LONDON consider 'transitional ' period data day analyse . A 3-day food diary keep intervention period . Weight patient record end period AYMES LONDON , acceptability questionnaire complete . Comparisons make baseline end phase study use appropriate analysis method .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>Adult patient ( â‰¥18 year ) able communicate view regard acceptability . Patients establish oral nutritional supplement , prescribe 12 ONS provide least 300kcal/day Patients expect require oral nutritional supplementation least 2 week . Informed consent obtain Participation study involve investigational market product concomitantly within two week prior entry study Patients require milk free Patients medical dietary contraindication feed ingredient ( see appendix 2 protocol full list ) Patients significant renal hepatic impairment Patients dysphagia require stage 1,2 3 thickened fluid Patients uncontrolled inflammatory bowel disease previous bowel resection ongoing gastrointestinal symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>